Delaware’s Two-Step “Bump-Up” Rule: Allegations Can Trigger the Clause, but Insurers Must Prove the Settlement Actually Increased Deal Consideration

1. Introduction

This decision addresses a recurring D&O insurance coverage dispute arising out of M&A-related litigation: whether a “bump-up” provision bars coverage for a settlement paid to resolve claims that shareholders received too little in a transaction.

Harman International Industries, Inc. (“Harman”) was acquired by Samsung Electronics Co., Ltd. (“Samsung”) in a reverse triangular merger for $112 per share. After closing, a shareholder class action (the “Baum Action”) alleged that Harman’s proxy disclosures were materially misleading in violation of §§14(a) and 20(a) of the Securities Exchange Act of 1934 and SEC Rule 14a-9, depriving shareholders of a fully informed vote and “the full and fair value” of their shares. The complaint sought damages measured as “the difference between the price Harman shareholders received and Harman’s true value at the time of the Acquisition.”

Harman settled for $28 million and sought coverage under a tower of D&O insurance issued by Illinois National Insurance Company (“AIG”), Federal Insurance Company (“Chubb”), and Berkley Insurance Company (“Berkley”). The insurers denied indemnity for the settlement, invoking each policy’s “Bump-Up Provision,” which excludes from “Loss” any settlement amount “representing the amount by which such price or consideration is effectively increased” when the underlying “Claim” alleges inadequate consideration for an acquisition.

The Delaware Supreme Court confronted two questions central to bump-up disputes:

• Claim step: Did a federal proxy-disclosure claim “alleg[e]” inadequate deal consideration?
• Loss step: Did the $28 million settlement “represent[]” an “effective[] increase[]” in the deal consideration?

2. Summary of the Opinion

2.1 What the Court affirmed—and what it corrected

The Superior Court had held that the bump-up provision did not apply because (i) the Baum Action did not allege inadequate consideration as a viable remedy under §§14(a)/20(a), and (ii) the settlement did not represent an effective increase in deal consideration. The Supreme Court:

• Disagreed with the Superior Court on the first step: the Baum Action did “allege” inadequate price/consideration because those allegations were “intrinsic to the theory” of the §14(a) claim.
• Agreed on the second step: the insurers did not prove the $28 million settlement represented an effective increase in deal consideration.

Because the bump-up provision requires both conditions, the Court affirmed coverage for the settlement.

2.2 Key evidentiary reasons insurers lost step two

The Court emphasized two record-based deficiencies:

• Class composition: the settlement class included people who “purchased, sold, or held” shares between the vote record period and closing, meaning some class members may have sold before closing and did not receive merger consideration capable of being “increased.”
• No valuation anchor: unlike cases with expert analyses of “true value,” the parties settled early with minimal discovery; insurers offered no evidence that the $28 million was calculated as an increment to the $112 price or tied to any measured deal underpayment.

The Court accepted that the record supported an alternative explanation: the settlement aligned with projected litigation costs (Harman claimed $25–30 million to litigate through trial), and the settlement recitals cited avoidance of expense and risk.

3. Analysis

3.1 The new Delaware rule: “two-step” bump-up application with a distinct proof burden on “representation”

The Court’s most practically important contribution is its insistence that step one cannot be allowed to swallow step two. A complaint can “allege” inadequate consideration, yet the resulting settlement may still be covered if the insurer cannot prove what the settlement represents.

3.2 Precedents cited—and how they shaped the decision

A. Delaware coverage and contract interpretation backbone

• In re Solera Ins. Coverage Appeals: Used for de novo review standards and for the Court’s practice of consulting dictionaries to determine plain meaning when policy terms are undefined.
• Ferrellgas Partners L.P. v. Zurich Am. Ins. Co. and Origis USA LLC v. Great Am. Ins. Co.: Reaffirmed Delaware’s objective, plain-meaning approach, and the doctrine of reasonable expectations for insurance contracts; also cited for construing the policy alongside the complaint in a coverage dispute.
• RSUI Indem. Co. v. Murdock: Provided the key insurance-law principles: broad construction of coverage aligned with reasonable expectations, strict and narrow construction of exclusions, and the insurer’s burden to prove an exclusion applies.
• Hallowell v. State Farm Mut. Auto. Ins. Co.: Quoted for the admonition that courts should not “destroy or twist” unambiguous policy language; also supports special construction rules for adhesion insurance contracts.
• AT&T Corp. v. Clarendon Am. Ins. Co.: Cited via RSUI for the strict treatment of exclusionary clauses (must be “specific, clear, plain, conspicuous” and consistent with public policy).
• Thompson St. Cap. Partners IV, L.P. v. Sonova United States Hearing Instruments, LLC: Reinforced that absent ambiguity, terms are given their “ordinary and usual meaning.”
• ACE Am. Ins. Co. v. Guaranteed Rate, Inc.: Addressed causation language (“arising out of”). Harman attempted to import its “meaningful linkage” concept into the word “allege,” but the Court rejected the analogy because the policy text here used “alleging,” not “arising out of.”

B. The bump-up provision “case law cluster”

The Court drew heavily from decisions interpreting similar bump-up provisions to validate its two-step structure and to separate “allegations” from “what the settlement represents.”

• Northrop Grumman Innovation Sys., Inc. v. Zurich American Ins. Co.: The Delaware Superior Court there first examined the underlying allegations and transaction, then asked what the settlement represented. The Supreme Court relied on it to support a two-step approach and, crucially, to illustrate how the “representing an effective increase” requirement can fail where the settlement is not shown to be a price bump. While Northrop Grumman had read an “only” limitation into the claim step, the Supreme Court here declined to require that inadequate consideration be the exclusive allegation.
• Towers Watson & Co. v. Nat'l Union Fire Ins. Co. of Pittsburgh, PA (Towers I and, collectively with Towers II, "Towers Watson") and Towers Watson & Co. v. National Union Fire Insurance Company of Pittsburgh, PA (Towers II): Central comparators. The Supreme Court agreed with the Fourth Circuit’s articulation that the provision imposes “two conditions.” But it distinguished the outcome on the record: Towers II involved a class largely comprised of shareholders who received deal consideration and featured an expert-driven valuation theory (true value minus consideration), supporting a conclusion that the “real result” was additional merger consideration.
• Joy Global, Inc. v. Columbia Casualty Company and Komatsu Mining Corp. v. Columbia Casualty Co.: The Court treated these as materially different because the policy language there did not require the second-step “representing an effective increase” analysis. The Supreme Court cited Joy Global mainly to clarify that policy wording matters; a broader exclusion can bar coverage without proving what the settlement represents.

C. Settlement-language skepticism

• In re CVS Opioid Ins. Litig.: The Court cited this to caution that settlement agreement language can be an unreliable coverage indicator because parties may tailor recitals to influence insurance outcomes. Although the Court considered settlement language here, it did not treat it as dispositive.

3.3 Legal reasoning

A. Step One: “Alleging” inadequate consideration is a low bar

The Court held that “allege” carries its ordinary meaning—an assertion “without proof or before proving.” It rejected adding a “viability” requirement (i.e., that inadequate consideration be a legally available remedy for the pleaded federal claims). Instead, it focused on whether inadequate consideration allegations were integral to the pleaded theory of injury and damages under §14(a).

Borrowing the conceptual approach from Towers Watson and recognizing how §14(a) private claims require injury causally linked to proxy solicitation, the Court concluded that Harman’s alleged disclosure failures were tied to shareholders not receiving “full and fair value,” and the complaint explicitly measured damages as the gap between deal price and “true value.” That was enough for step one.

B. Step Two: “Representing” an “effectively increased” price demands proof of what the settlement paid for

Step two did the real work. The Court interpreted “represent” and “effectively” (including by dictionary) to ask whether the “real result” of the settlement was to increase transaction consideration for the shareholders’ relinquished shares.

The Court then anchored the inquiry in record evidence, not generalities:

• Class definition problem: The settlement class encompassed investors who “purchased, sold, or held” during a window that did not require holding through closing. Because the record did not establish that all class members received merger consideration, the Court was unwilling to assume the settlement functioned as an across-the-board price bump.
• Absence of valuation proof or allocation logic: Unlike Towers II, no expert report or other evidence tied the $28 million to an appraisal-like increment over $112 per share (or to any quantified “true value”). The settlement occurred early with limited discovery; insurers offered no evidence of how the figure was derived in a “deal-price deficiency” sense.
• Litigation-cost explanation fit the record: The settlement amount roughly tracked projected defense costs ($25–30 million) and the settlement recitals emphasized avoiding expense and risk. The Court accepted this as a plausible—and evidentially supported—representation of what the settlement paid for.

In short, Delaware required insurers to prove that the settlement amount (or a portion) functioned as consideration augmentation, not merely that the complaint framed damages in those terms.

3.4 Impact

A. For Delaware D&O bump-up disputes

• Clear bifurcation of claim vs. loss: Delaware now squarely emphasizes that satisfying the “claim alleging inadequate consideration” condition does not automatically satisfy the “settlement representing an effective increase” condition.
• Evidentiary burden on insurers increases: Insurers should expect to develop a record showing (i) who received merger consideration, (ii) whether settlement distributions tracked consideration recipients, and (iii) whether settlement value was derived from a valuation gap (expert work, mediation statements, damages models, negotiation history) rather than litigation-cost avoidance.
• Class definitions matter: Settlements that include purchasers/sellers in a window not tied to closing may undermine an insurer’s ability to characterize the payment as an “effective increase” in deal consideration.
• Earlier settlements may be harder to exclude: When discovery is limited and valuation evidence absent, insurers may have difficulty proving what the settlement “represents,” especially under Delaware’s strict construction of exclusions.

B. For policy drafting and underwriting

• Wording sensitivity: The Court’s discussion of Joy Global underscores that broader exclusions (e.g., barring any settlement of an “Inadequate Consideration Claim”) may avoid step-two disputes. Carriers may respond by revising bump-up language, while insureds may negotiate for the narrower “representing an effective increase” phrasing.
• Allocation and proof provisions: Expect greater emphasis on allocation clauses, cooperation provisions, and settlement reporting to preserve evidence relevant to “representation” disputes.

4. Complex Concepts Simplified

• D&O insurance: Coverage for directors/officers and sometimes the company itself for claims alleging wrongful acts, including securities claims.
• Reverse triangular merger: An acquisition structure where the buyer’s subsidiary merges into the target, and the target survives as a subsidiary of the buyer.
• §14(a) / Rule 14a-9 proxy claim: A federal claim that a proxy statement contained a material misstatement or omission that caused injury and was essential to accomplishing the transaction.
• “Bump-up” provision: A policy term aimed at preventing insurance from funding an increase in deal price—i.e., stopping insureds from using coverage to pay what is essentially additional acquisition consideration.
• Two-step test (this case):
  1. Did the complaint allege inadequate deal consideration? (Here: yes.)
  2. Did the settlement actually function as an increase in deal consideration? (Here: insurers failed to prove it.)
• Summary judgment: A decision without trial when no genuine dispute of material fact exists; here, the insurers’ failure of proof on what the settlement “represented” was decisive.

5. Conclusion

The Delaware Supreme Court’s decision establishes a practically significant constraint on bump-up provisions with “representing an effective increase” language: insurers must do more than point to a complaint’s deal-underpayment allegations. Even when a §14(a) disclosure complaint “alleges” inadequate consideration, the carrier must prove, with record evidence, that the settlement amount (or a portion) actually represented an effective increase in transaction consideration. Where the settlement class is not clearly limited to closing-date recipients and the record lacks valuation-based linkage for the settlement figure, Delaware will not presume a “bump-up,” and coverage will remain available.